Lilly, Boehringer diabetes drug cuts heart attack, stroke risk in trial
 

Lilly, Boehringer diabetes drug cuts heart attack, stroke risk in trial
(Reuters) - A new diabetes pill from Eli Lilly and Co and Boehringer Ingelheim cut risk of heart attack, stroke and death in a closely watched study, the first glucose-lowering drug to show such protective results in a large cardiovascular trial, the drugmakers said on Thursday.
http://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Uw:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...Uw:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/vhgmafX-OY8